 |
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
| |
Diane Wara, M.D., Chair, NIH RAC |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0410-677 |
|
|
| |
Phase I Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV-RPE65) Gene Vector in Patients with Retinal Disease Due to RPE65 Mutations |
|
|
| |
Samuel G. Jacobson, M.D., Ph.D., Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia, PA |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
Biological Containment for Work with Noncontemporary Strains of Influenza |
|
|
| |
Harmonization of the NIH Guidelines with Other Federal Guidances |
|
|
| |
Jacqueline Katz, Ph.D., U.S. Centers for Disease Control and Prevention, Altanta, Ga |
|
|
| |
Slides 1
Slides 2
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0504-707 |
|
|
| |
Dose-Finding and Safety Study of an Oncolytic Polio/Rhinovirus against Malignant Glioma |
|
|
| |
Darrell D. Bigner, M.D., Ph.D., Duke University Medical Center, Durham, NC |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
ADJOURN |
|
| |
